Diagnosis and Treatment of Co-infection With Human Immunodeficiency Virus /Latent Tuberculosis Infection (HIV/TBL)

NCT01875952 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Human Immunodeficiency Virus (HIV)
Tuberculosis (TB)
Latent Tuberculosis Infection (LTI)

Interventions

DRUG: Isoniazid

Sponsor

Instituto Nacional de Salud Publica, Mexico

Collaborators

[object Object]
[object Object]